| Literature DB >> 34633614 |
Piotr Małczak1, Magdalena Mizera2, Yung Lee3, Magdalena Pisarska-Adamczyk4, Michał Wysocki5, Małgorzata M Bała6, Jan Witowski2, Mateusz Rubinkiewicz2, Alicja Dudek2, Tomasz Stefura2, Grzegorz Torbicz5, Piotr Tylec2, Natalia Gajewska2, Tanawat Vongsurbchart2, Michael Su2, Piotr Major2, Michał Pędziwiatr2.
Abstract
OBJECTIVE: Comprehensive analysis and comparison of HRQoL following different bariatric interventions through systematic review with network meta-analysis.Entities:
Keywords: Bariatric surgery; Network meta-analysis; Quality of life
Mesh:
Year: 2021 PMID: 34633614 PMCID: PMC8595157 DOI: 10.1007/s11695-021-05687-1
Source DB: PubMed Journal: Obes Surg ISSN: 0960-8923 Impact factor: 4.129
Fig. 1PRISMA flowchart
Basic characteristics of the included studies
| First author | Year of publication | Country | Single/multi-center | Study type | QoL form | Study arms | Intervention type | Quality score/risk of bias |
|---|---|---|---|---|---|---|---|---|
| Lee [ | 2004 | Taiwan | Single | RCT | GIQLI | 2 | VBG/LRYGB | High risk |
| Lee [ | 2005 | Taiwan | Single | RCT | GIQLI | 2 | LRYGB/OAGB | High risk |
| Müller [ | 2008 | Switzerland | Single | Cohort | SF-36, MA | 2 | LRYGB/LAGB | 8 |
| Campos [ | 2011 | USA | Single | Cohort | BAROS | 2 | LAGB/LRYGB | 8 |
| Søvik [ | 2011 | Norway, Sweden | Multi | RCT | SF-36 | 2 | LRYGB/BPD-S | High risk |
| Alley [ | 2012 | USA | Single | Cohort | BQL | 2 | LSG/LAGB | 8 |
| Lee [ | 2012 | Taiwan | Single | Cohort | GIQLI | 2 | LRYGB/OAGB | 8 |
| Carlin [ | 2013 | USA | Multi | Cohort | BQL | 3 | LRYGB/LSG/LAGB | 7 |
| Karlsen [ | 2013 | Norway | Single | Cohort | SF-36, OWLQOL | 2 | LRYGB/LI | 7 |
| O’Brien [ | 2013 | Australia | Single | RCT | SF-36 | 3 | LAGB/crossed-over/LI | High risk |
| Kaseja [ | 2014 | Poland | Single | Cohort | MA | 2 | LSG/LRYGB | 8 |
| Duarte [ | 2014 | Brasil | Single | Cohort | SF-36, BAROS | 3 | BPD-DS/banded-GB/no intervention | 6 |
| Strain [ | 2014 | USA | Multi | Cohort | IWQOL-Lite, SF-36 | 4 | LRYGB/BPD-DS/LSG/LAGB | 7 |
| Schauer [ | 2014 | USA | Single | RCT | RAND-36 | 3 | LI/LRYGB/LSG | High risk |
| Bhandari [ | 2015 | India | Single | Cohort | GIQLI | 2 | Banded-GB/LRYGB | 7 |
| Major [ | 2015 | Poland | Single | Cohort | SF-36, BAROS | 2 | LSG/LRYGB | 5 |
| Lee [ | 2015 | Taiwan | Single | Cohort | GIQLI | 3 | LSG/LRYGB/OAGB | 6 |
| Barr [ | 2016 | USA | Single | Cohort | GERD-HRQL | 2 | LRYGB/LSG | 7 |
| Buzgova [ | 2016 | Czech Republic | Single | Cohort | WHOQOL-BREF, HADS | 2 | LSG/LGCP | 7 |
| Figura [ | 2016 | Germany | Single | Cohort | SF-8 | 2 | LSG/LI | 8 |
| Risstad [ | 2016 | Sweden | Multi | RCT | SF-36 | 2 | LRYGB/distal-GB | Low risk |
| Ignat [ | 2016 | France | Single | RCT | MA, GIQLI | 2 | LRYGB/LSG | High risk |
| Janik [ | 2016 | Poland | Single | Cohort | MA | 3 | LRYGB/LSG/no intervention | 8 |
| Nickel [ | 2016 | Germany | Single | Cohort | GIQLI | 2 | LRYGB/LSG | 4 |
| Omotosho [ | 2016 | USA | Single | Cohort | SF-36 | 2 | LRYGB/LI | 8 |
| Panosian [ | 2016 | USA | Single | RCT | SF-36, IWQOL-Lite | 2 | LRYGB/LI | High risk |
| Accardi [ | 2017 | Italy | Multi | Cohort | LQ | 2 | LRYGB/LAGB | 5 |
| Elrefai [ | 2017 | Germany | Single | Cohort | BQL | 4 | LRYGB/LSG/BPD-DS/LAGB | 7 |
| Biter [ | 2017 | Netherlands | Single | RCT | BAROS, SF-36 | 2 | LSG/LRYGB | High risk |
| Peterli [ | 2017 | Switzerland | Multi | RCT | GIQLI, BAROS | 2 | LSG/LRYGB | High risk |
| Svanevik [ | 2017 | Norway | Multi | RCT | MA, OWLQOL | 2 | LRYGB/distal-GB | Low risk |
| Versteegden DPA [ | 2017 | Netherlands | Single | Cohort | RAND-36 | 2 | LSG/LRYGB | 6 |
| Schauer [ | 2017 | USA | Single | RCT | RAND-36 | 3 | LI/LRYGB/LSG | High risk |
| Salminen [ | 2018 | Finland | Multi | RCT | MA | 2 | LSG/LRYGB | High risk |
| Homan [ | 2018 | Netherlands | Single | RCT | RAND-36 | 2 | LRYGB/LB-GB | High risk |
| Peterli [ | 2018 | Switzerland | Multi | RCT | GIQLI | 2 | LSG/LRYGB | High risk |
| Elias [ | 2018 | Sweden | Single | Cohort | SF-36 | 2 | LRYGB/BPD-DS | 7 |
| Silva [ | 2018 | Portugal | Single | Cohort | RAND-36 | 2 | LRYGB/LSG | 6 |
| Catheline [ | 2019 | France | Multi | RCT | SF-36 | 2 | LSG/LRYGB | 8 |
| Nabil [ | 2019 | Egypt | Multi | RCT | GIQLI | 2 | OAGB/distal-OAGB | High risk |
| Skogar [ | 2020 | Sweden | NR | Cohort | SF-36 | 2 | BPD-DS/LRYGB | 8 |
| Lechaux [ | 2020 | France | Single | Cohort | MA | 2 | LSG/OAGB | 5 |
| Monpellier [ | 2020 | Netherlands | Multi | Cohort | RAND-36 | 2 | LSG/LRYGB | 7 |
| Poelemeijer [ | 2020 | Netherlands | NR | Cohort | RAND-36 | 2 | LSG/LRYGB | 7 |
QoL, Quality of Life; BQL, Bariatric Quality of Life; LQ, Laval Questionnaire; GERD-HRQL, GERD-Health-Related Quality of Life Questionnaire; WHOQOL-BREF, World Health Organization Quality of Life Instruments; SF-8, Short Form 8 Health Survey; BAROS, Bariatric Analysis and Reporting Outcome System; MA, Moorehead-Ardelt Quality of Life Questionnaire; GIQLI, Gastrointestinal Quality of Life Index; SF-36, Short Form 36 Health Survey; OWLQOL, Obesity and Weight-Loss Quality of Life; RAND-36, Rand 36-Item Health Survey; IWQOL-Lite, Impact of Weight on Quality of Life-Lite; LI, lifestyle intervention; LSG, laparoscopic sleeve gastrectomy; LRYGB, laparoscopic Roux-en-Y gastric bypass; BPD-DS, laparoscopic biliopancreatic diversion with duodenal switch; VBG, vertical banded gastroplasty; LAGB, laparoscopic adjustable gastric banding; LGCP, laparoscopic greater curvature plication; OAGB, one anastomosis gastric bypass; banded-GB, banded laparoscopic Roux-en-Y gastric bypass; Distal-GB, distal laparoscopic Roux-en-Y gastric bypass; Distal-OAGB, distal one anastomosis gastric bypass; LB-GB, prolonged biliopancreatic limb gastric bypass; RCT, randomized controlled trial; NR, national registry
Fig. 2Study network in the meta-analysis A at 1 year, B at 2 years, C at 3 years, D at 5 years follow-up
Fig. 3Pooled results of total HRQoL presented as SMD after 1 year a in comparison to lifestyle intervention; b pairwise comparisons between surgeries
HRQoL after 1 year presented GIQLI scale (0–144)
MD > 0 favors intervention in row; MD < 0 favors intervention in column; MCID > 5 marked green
HRQoL, health-related quality of life; LI, lifestyle intervention; LSG, laparoscopic sleeve gastrectomy; LRYGB, laparoscopic Roux-en-Y gastric bypass; Distal-OAGB, distal one anastomosis gastric bypass; BPD-DS, laparoscopic biliopancreatic diversion with duodenal switch; VBG, vertical banded gastroplasty; LAGB, laparoscopic adjustable gastric banding; LGCP, laparoscopic greater curvature plication; OAGB, one anastomosis gastric bypass
HRQoL after 2 years presented GIQLI scale (0–144)
MD > 0 favors intervention in row; MD < 0 favors intervention in column; MCID > 5 marked green
HRQoL, health-related quality of life; LI, lifestyle intervention; LSG, laparoscopic sleeve gastrectomy; LRYGB, laparoscopic Roux-en-Y gastric bypass; BPD-DS, laparoscopic biliopancreatic diversion with duodenal switch; LAGB, laparoscopic adjustable gastric banding; OAGB, one anastomosis gastric bypass; banded-GB, banded Roux-en-Y gastric bypass; Distal-GB, distal Roux-en-Y gastric bypass; LB-GB, prolonged biliopancreatic limb gastric bypass
Fig. 4Pooled results of total HRQoL presented as SMD at 2 years a in comparison to lifestyle intervention; b pairwise comparisons between surgeries